U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021179
Company: GENZYME
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
RENAGEL SEVELAMER HYDROCHLORIDE 400MG TABLET;ORAL Prescription AB Yes No
RENAGEL SEVELAMER HYDROCHLORIDE 800MG TABLET;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/12/2000 ORIG-1 Approval Type 3 - New Dosage Form STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21179lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21179ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-179_Renagel.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/22/2023 SUPPL-39 Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021179Orig1s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021179Orig1s039ltr.pdf
04/30/2020 SUPPL-38 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021179s038lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021179Orig1s038ltr.pdf
02/21/2019 SUPPL-37 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021179s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021179Orig1s037ltr.pdf
03/09/2016 SUPPL-32 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021179s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021179Orig1s032ltr.pdf
06/09/2015 SUPPL-31 Manufacturing (CMC)

Label is not available on this site.

11/26/2014 SUPPL-30 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021179Orig1s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021179Orig1s030ltr.pdf
06/16/2011 SUPPL-29 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021179s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021179s029,022127s008,022318s003ltr.pdf
08/14/2007 SUPPL-21 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021179s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021179s021LTR.pdf
10/19/2007 SUPPL-20 Efficacy-Labeling Change With Clinical Data Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021179s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021179s020ltr.pdf
07/25/2005 SUPPL-15 Labeling Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021179s015ltr.pdf
01/07/2003 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

02/06/2004 SUPPL-2 Efficacy-Labeling Change With Clinical Data Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20926se1-006,21179se1-002ltr.pdf
03/15/2002 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/22/2023 SUPPL-39 Manufacturing (CMC) Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021179Orig1s039lbl.pdf
04/30/2020 SUPPL-38 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021179s038lbl.pdf
02/21/2019 SUPPL-37 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021179s037lbl.pdf
03/09/2016 SUPPL-32 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021179s032lbl.pdf
11/26/2014 SUPPL-30 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021179Orig1s030lbl.pdf
06/16/2011 SUPPL-29 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021179s029lbl.pdf
10/19/2007 SUPPL-20 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021179s020lbl.pdf
08/14/2007 SUPPL-21 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021179s021lbl.pdf
07/12/2000 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21179lbl.pdf

RENAGEL

TABLET;ORAL; 400MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
RENAGEL SEVELAMER HYDROCHLORIDE 400MG TABLET;ORAL Prescription Yes AB 021179 GENZYME
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 400MG TABLET;ORAL Prescription No AB 212599 AUROBINDO PHARMA LTD
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 400MG TABLET;ORAL Prescription No AB 204724 GLENMARK PHARMS LTD
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 400MG TABLET;ORAL Prescription No AB 213145 LUPIN LTD
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 400MG TABLET;ORAL Prescription No AB 206883 MACLEODS PHARMS LTD

TABLET;ORAL; 800MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
RENAGEL SEVELAMER HYDROCHLORIDE 800MG TABLET;ORAL Prescription Yes AB 021179 GENZYME
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 800MG TABLET;ORAL Prescription No AB 212599 AUROBINDO PHARMA LTD
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 800MG TABLET;ORAL Prescription No AB 204724 GLENMARK PHARMS LTD
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 800MG TABLET;ORAL Prescription No AB 213145 LUPIN LTD
SEVELAMER HYDROCHLORIDE SEVELAMER HYDROCHLORIDE 800MG TABLET;ORAL Prescription No AB 206883 MACLEODS PHARMS LTD
Back to Top